Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumours
Patrick Schöffski, Suzanne F. Jones, Herlinde Dumez, Jeffrey R. Infante, Elke Van Mieghem, Camilla Fowst, Paola Gerletti, Huiping Xu, John L. Jakubczak, Patricia A. English, Kristen J. Pierce, HowardVolume:
47
Year:
2011
Language:
english
Pages:
2265
DOI:
10.1016/j.ejca.2011.07.008
File:
PDF, 215 KB
english, 2011